Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2008

Open Access 01-05-2008 | clinical-patient Studies

The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study

Authors: I. Bosma, C. J. Stam, L. Douw, F. Bartolomei, J. J. Heimans, B. W. van Dijk, T. J. Postma, M. Klein, J. C. Reijneveld

Published in: Journal of Neuro-Oncology | Issue 1/2008

Login to get access

Abstract

Purpose In the present MEG-study, power spectral analysis of oscillatory brain activity was used to compare resting state brain activity in both low-grade glioma (LGG) patients and healthy controls. We hypothesized that LGG patients show local as well as diffuse slowing of resting state brain activity compared to healthy controls and that particularly global slowing correlates with neurocognitive dysfunction. Patient and methods Resting state MEG recordings were obtained from 17 LGG patients and 17 age-, sex-, and education-matched healthy controls. Relative spectral power was calculated in the delta, theta, upper and lower alpha, beta, and gamma frequency band. A battery of standardized neurocognitive tests measuring 6 neurocognitive domains was administered. Results LGG patients showed a slowing of the resting state brain activity when compared to healthy controls. Decrease in relative power was mainly found in the gamma frequency band in the bilateral frontocentral MEG regions, whereas an increase in relative power was found in the theta frequency band in the left parietal region. An increase of the relative power in the theta and lower alpha band correlated with impaired executive functioning, information processing, and working memory. Conclusion LGG patients are characterized by global slowing of their resting state brain activity and this slowing phenomenon correlates with the observed neurocognitive deficits.
Literature
1.
go back to reference Shaw EG, Scheithauer BW, O’Fallon JR (1993) Management of supratentorial low-grade gliomas. Oncology 7(7):97–111PubMed Shaw EG, Scheithauer BW, O’Fallon JR (1993) Management of supratentorial low-grade gliomas. Oncology 7(7):97–111PubMed
2.
go back to reference Shaw EG, Daumas-Duport C, Scheithauer BW et al (1989) Radiation therapy in the mangement of low-grade supratentorial astrocytomas. J Neurosurg 70:853–861PubMed Shaw EG, Daumas-Duport C, Scheithauer BW et al (1989) Radiation therapy in the mangement of low-grade supratentorial astrocytomas. J Neurosurg 70:853–861PubMed
3.
go back to reference Reijneveld JC, Sitskoorn MM, Klein M et al (2001) Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56:618–623PubMed Reijneveld JC, Sitskoorn MM, Klein M et al (2001) Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56:618–623PubMed
4.
go back to reference Wessels PH, Weber WE, Raven G et al (2003) Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 7(2):395–403CrossRef Wessels PH, Weber WE, Raven G et al (2003) Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 7(2):395–403CrossRef
5.
go back to reference van den Bent MJ, Afra D, de Witte O et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 336:985–990 van den Bent MJ, Afra D, de Witte O et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 336:985–990
6.
go back to reference Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361–1368PubMedCrossRef Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361–1368PubMedCrossRef
7.
go back to reference Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159–168PubMedCrossRef Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159–168PubMedCrossRef
8.
go back to reference Dierks T, Ihl R, Frolich L, Maurer K (1993) Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatr Res 50(3):151–162CrossRef Dierks T, Ihl R, Frolich L, Maurer K (1993) Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatr Res 50(3):151–162CrossRef
9.
go back to reference Jelic V, Johansson SE, Almkvist O et al (2002) Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease. Neurobiol Aging 21(4):533–540CrossRef Jelic V, Johansson SE, Almkvist O et al (2002) Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease. Neurobiol Aging 21(4):533–540CrossRef
10.
go back to reference Babiloni C, Binetti G, Casseta E et al (2004) Mapping distributed sources of cortical rythms in mild Alzheimer’s disease. A multicentric EEG study. Neuroimage 22:57–67PubMedCrossRef Babiloni C, Binetti G, Casseta E et al (2004) Mapping distributed sources of cortical rythms in mild Alzheimer’s disease. A multicentric EEG study. Neuroimage 22:57–67PubMedCrossRef
11.
go back to reference Soikkeli R, Partanen J, Soininen H et al (1991) Slowing of EEG in Parkinson’s disease. Electroencephalogr Clin Neurophysiol 79(3):159–165PubMedCrossRef Soikkeli R, Partanen J, Soininen H et al (1991) Slowing of EEG in Parkinson’s disease. Electroencephalogr Clin Neurophysiol 79(3):159–165PubMedCrossRef
12.
go back to reference Neufeld MY, Blumen S, Aitkin I, Parmet Y, Korczyn AD (1994) EEG frequency analysis in demented and nondemented parkinsonian patients. Dementia 5(1):23–28PubMedCrossRef Neufeld MY, Blumen S, Aitkin I, Parmet Y, Korczyn AD (1994) EEG frequency analysis in demented and nondemented parkinsonian patients. Dementia 5(1):23–28PubMedCrossRef
13.
go back to reference Sinanovic O, Kapidzic A, Kovacevic L et al (2005) EEG frequency and cognitive dysfunction in patients with Parkinson’s disease. Med Arh 59(5):286–287PubMed Sinanovic O, Kapidzic A, Kovacevic L et al (2005) EEG frequency and cognitive dysfunction in patients with Parkinson’s disease. Med Arh 59(5):286–287PubMed
14.
go back to reference Schnitzler A, Gross J (2005) Normal and pathological oscillatory communication in the brain. Nature reviews neuroscience 6:285–296PubMedCrossRef Schnitzler A, Gross J (2005) Normal and pathological oscillatory communication in the brain. Nature reviews neuroscience 6:285–296PubMedCrossRef
15.
go back to reference Uhlhaas PJ, Singer W (2006) Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathofysiology. Neuron 52:155–168PubMedCrossRef Uhlhaas PJ, Singer W (2006) Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathofysiology. Neuron 52:155–168PubMedCrossRef
16.
go back to reference Fernandez A, Maestu F, Amo C et al (2002) Focal temporoparietal slow activity in Alzheimer’s disease revealed by magnetoencephalography. Biol Psychiatry 52:764–770PubMedCrossRef Fernandez A, Maestu F, Amo C et al (2002) Focal temporoparietal slow activity in Alzheimer’s disease revealed by magnetoencephalography. Biol Psychiatry 52:764–770PubMedCrossRef
17.
go back to reference Franciotti R, Iacono D, Della Penna S et al (2006) Cortical rythms reactivity in AD, LBD, and normal subjects: a quantitative MEG study. Neurobiol aging 27(8):1100–1109PubMedCrossRef Franciotti R, Iacono D, Della Penna S et al (2006) Cortical rythms reactivity in AD, LBD, and normal subjects: a quantitative MEG study. Neurobiol aging 27(8):1100–1109PubMedCrossRef
18.
go back to reference Kotini A, Anninos P, Adamopoulos A et al (2005) Low-frequency MEG activity and MRI evaluation in Parkinson’s disease. Brain Topography 18(1):59–63PubMedCrossRef Kotini A, Anninos P, Adamopoulos A et al (2005) Low-frequency MEG activity and MRI evaluation in Parkinson’s disease. Brain Topography 18(1):59–63PubMedCrossRef
19.
go back to reference Bosboom JLW, Stoffers D, Stam CJ et al (2006) Resting state oscillatory brain dynamics in Parkinson’s disease: a MEG study. Clin Neurophysiol 117:2521–2531PubMedCrossRef Bosboom JLW, Stoffers D, Stam CJ et al (2006) Resting state oscillatory brain dynamics in Parkinson’s disease: a MEG study. Clin Neurophysiol 117:2521–2531PubMedCrossRef
20.
go back to reference Stoffers D, Bosboom JLW, Deijen JB et al (2007) Slowing of oscillatory brain activity is a stable characteristic of Parkinson’s disease without dementia. Brain 130:1847–1860PubMedCrossRef Stoffers D, Bosboom JLW, Deijen JB et al (2007) Slowing of oscillatory brain activity is a stable characteristic of Parkinson’s disease without dementia. Brain 130:1847–1860PubMedCrossRef
21.
go back to reference Oshino S, Kato A, Wakayama A et al (2007) Magnetoencephalographic analysis of cortical oscillatory activity in patients with brain tumors: synthetic aperture magnetography (SAM) functional imaging of delta band activity. Neuroimage 34:957–964PubMedCrossRef Oshino S, Kato A, Wakayama A et al (2007) Magnetoencephalographic analysis of cortical oscillatory activity in patients with brain tumors: synthetic aperture magnetography (SAM) functional imaging of delta band activity. Neuroimage 34:957–964PubMedCrossRef
22.
go back to reference de Jongh A, Baayen JC, de Munck JC et al (2003) The influence of brain tumor treatment on pathological delta activity in MEG. Neuroimage 20:2291–2301PubMedCrossRef de Jongh A, Baayen JC, de Munck JC et al (2003) The influence of brain tumor treatment on pathological delta activity in MEG. Neuroimage 20:2291–2301PubMedCrossRef
23.
go back to reference de Jongh A, de Munck JC, Baayen JC et al (2003) Localization of fast MEG waves in patients with brain tumors and epilepsy. Brain topography 15(3):173–179PubMedCrossRef de Jongh A, de Munck JC, Baayen JC et al (2003) Localization of fast MEG waves in patients with brain tumors and epilepsy. Brain topography 15(3):173–179PubMedCrossRef
24.
go back to reference Bartolomei F, Bosma I, Klein M et al (2006) How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol 59(1):128–138PubMedCrossRef Bartolomei F, Bosma I, Klein M et al (2006) How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol 59(1):128–138PubMedCrossRef
25.
go back to reference Bartolomei F, Bosma I, Klein M et al (2006) Disturbed functional connectivity in brain tumour patients: evaluation by graph analysis of synchronization matrices. Clin Neurophysiol 117(9):2039–2049PubMedCrossRef Bartolomei F, Bosma I, Klein M et al (2006) Disturbed functional connectivity in brain tumour patients: evaluation by graph analysis of synchronization matrices. Clin Neurophysiol 117(9):2039–2049PubMedCrossRef
26.
go back to reference Vrba J, Anderson G, Betts K (1999) 151-Channel whole-cortex MEG system for seated or supine positions, recent advances in biomagnetism. Tohoku University Press, Sendai, pp 93–96 Vrba J, Anderson G, Betts K (1999) 151-Channel whole-cortex MEG system for seated or supine positions, recent advances in biomagnetism. Tohoku University Press, Sendai, pp 93–96
27.
go back to reference Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York
28.
go back to reference Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53–60CrossRef Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53–60CrossRef
29.
go back to reference Houx PJ, Jolles J (1994) Vulnerability factors for age-related cognitive decline. In: Jensen KF (ed) The vulnerable brain and environmental risks, vol 3. Plenum Press, New York, pp 25–41 Houx PJ, Jolles J (1994) Vulnerability factors for age-related cognitive decline. In: Jensen KF (ed) The vulnerable brain and environmental risks, vol 3. Plenum Press, New York, pp 25–41
30.
go back to reference Klein M, Postma TJ, Taphoorn MJ et al (2003) The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61(12):1796–1798PubMed Klein M, Postma TJ, Taphoorn MJ et al (2003) The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61(12):1796–1798PubMed
31.
go back to reference Bosma H, van Boxtel MP, Ponds RW et al (2000) Pesticide exposure and risk of mild cognitive dysfunction. Lancet 356(9233):912–913PubMedCrossRef Bosma H, van Boxtel MP, Ponds RW et al (2000) Pesticide exposure and risk of mild cognitive dysfunction. Lancet 356(9233):912–913PubMedCrossRef
32.
go back to reference Vos MJ, Uitdehaag BM, Barkhof F et al (2003) Interobserver variability in the radiological assesment of response to chemotherapy in glioma. Neurology 61(12):826–830 Vos MJ, Uitdehaag BM, Barkhof F et al (2003) Interobserver variability in the radiological assesment of response to chemotherapy in glioma. Neurology 61(12):826–830
33.
go back to reference Gootjes L, Bouma A, Van Strien JW, Scheltens P, Stam CJ (2006) Attention modulates hemispheric differences in functional connectivity; Evidence from MEG recordings. Neuroimage 30:245–253PubMedCrossRef Gootjes L, Bouma A, Van Strien JW, Scheltens P, Stam CJ (2006) Attention modulates hemispheric differences in functional connectivity; Evidence from MEG recordings. Neuroimage 30:245–253PubMedCrossRef
34.
go back to reference Hochberg FH, Slotnick B (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30(2):172–177PubMed Hochberg FH, Slotnick B (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30(2):172–177PubMed
35.
go back to reference Taphoorn MJ, Heimans JJ, Snoek FJ et al (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55(5):372–376PubMedCrossRef Taphoorn MJ, Heimans JJ, Snoek FJ et al (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55(5):372–376PubMedCrossRef
36.
go back to reference Taphoorn MJ, Schiphorst AK, Snoek FJ et al (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36(1):48–44PubMedCrossRef Taphoorn MJ, Schiphorst AK, Snoek FJ et al (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36(1):48–44PubMedCrossRef
37.
go back to reference Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8):1305–1309PubMedCrossRef Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8):1305–1309PubMedCrossRef
38.
go back to reference Shaw EG, Rosdhal R, D’Agostino RB et al (2006) Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24(9):1415–1420PubMedCrossRef Shaw EG, Rosdhal R, D’Agostino RB et al (2006) Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24(9):1415–1420PubMedCrossRef
Metadata
Title
The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study
Authors
I. Bosma
C. J. Stam
L. Douw
F. Bartolomei
J. J. Heimans
B. W. van Dijk
T. J. Postma
M. Klein
J. C. Reijneveld
Publication date
01-05-2008
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2008
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-008-9535-3

Other articles of this Issue 1/2008

Journal of Neuro-Oncology 1/2008 Go to the issue

lab. investigation-human/Animal Tissue

Expression of TLR9 within human glioblastoma